Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120300) titled 'A real world study of polyene phosphatidylcholine injection for the prevention and treatment of DILI in patients with malignant hematological diseases' on March 11.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Condition:
Drug-Induced Liver Injury (DILI)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-31
Target Sample Size: Observation group:1000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org...